Filing Details
- Accession Number:
- 0001225208-14-004279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-12 14:41:18
- Reporting Period:
- 2014-02-10
- Filing Date:
- 2014-02-12
- Accepted Time:
- 2014-02-12 14:41:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1171315 | L Tony White | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-10 | 1,200 | $57.01 | 13,395 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-10 | 1,200 | $54.97 | 14,595 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-10 | 2,400 | $132.97 | 12,195 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2014-02-10 | 1,200 | $0.00 | 1,200 | $54.97 |
Common Stock | Option (Right to Buy) | Disposition | 2014-02-10 | 1,200 | $0.00 | 1,200 | $57.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-07-14 | No | 4 | M | Direct | |
0 | 2014-09-08 | No | 4 | M | Direct |
Footnotes
- Includes 19.887 shares acquired under the Company's Dividend Reinvestment Plan from December 12, 2013 to February 10, 2014.
- Represents the weighted average sales price for price increments ranging from $132.97 to $132.972. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
- Award/Grant pursuant to the 2005 Directors' Stock Award Plan, as amended and restated (formerly known as the 1988 Directors' Stock Award Plan).
- Options vested in three equal installments beginning on July 14, 2005 and are curently exercisable.
- Options vested in three equal installments beginning on September 8, 2005 and are currently exercisable.